Interventions to Improve Adolescent Vaccination What May Work and What Still Needs to Be Tested by Dempsey, Amanda F. & Zimet, Gregory D.
 
 
This is the author's manuscript of the article published in final edited form as:   
 
Dempsey, A. F., & Zimet, G. D. (2015). Interventions to Improve Adolescent Vaccination: What May Work and 
What Still Needs to Be Tested. American Journal of Preventive Medicine, 49(6, Supplement 4), S445–S454. 
http://doi.org/10.1016/j.amepre.2015.04.013 
Interventions to Improve Adolescent Vaccination 
What May Work and What Still Needs to Be Tested 
 
Amanda F. Dempsey, MD, PhD, MPH, Gregory D. Zimet, PhD 
 
From the Adult and Child Center for Outcomes Research and Dissemination Science program 
(Dempsey), University of Colorado Denver, Aurora, Colorado; and Section of Adolescent 
Medicine (Zimet), Indiana University School of Medicine, Indianapolis, Indiana 
 
Address correspondence to: Amanda. F. Dempsey, MD, PhD, MPH, ACCORDS Program, 
University of Colorado Denver, 13199 East Montview Blvd, Suite 300, Aurora CO 80045. E-
mail: amanda.dempsey@ucdenver.edu. 
This article is being published concurrently in the American Journal of Preventive Medicine and 
Vaccine. The articles are identical except for stylistic changes in keeping with each journalʼs 
style. Either of these versions may be used in citing this article. Publication of this article was 
supported by Merck and Novartis. 
Author Disclosures:  
Dr. Zimet is an investigator on investigator-initiated research funded by Merck & Co., Inc.  
Amanda Dempsey serves on advisory boards for Merck and Pfizer. She does not receive any 
research support from either company. 
  
2 
Abstract 
Since the development of the “adolescent platform” of vaccination in 1997, hundreds of studies 
have been conducted, identifying barriers to and facilitators of adolescent vaccination. More 
recent research has focused on developing and evaluating interventions to increase uptake of 
adolescent vaccines. This review describes a selection of recent intervention studies for 
increasing adolescent vaccination, divided into three categories: those with promising results that 
may warrant more widespread implementation, those with mixed results requiring more research, 
and those with proven effectiveness in other domains that have not yet been tested with regard to 
adolescent vaccination. 
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Introduction 
Vaccination is a cornerstone of adolescent preventive care in the U.S. Since the introduction of 
routine vaccination during childhood and adolescents, it is estimated that more than 732,000 
deaths and more than 21 million hospitalizations have been averted in the U.S. alone over the last 
20 years due to the prevention of diseases by vaccines. 1 Though these successes are to be 
celebrated, there is still much work to be done.  In fact, 2011 marked the beginning of the 
“decade of vaccines” in recognition of the need for efforts to expand vaccine coverage in regions 
of the world with low vaccine access, and to continue, and even strengthen, efforts to maintain 
high coverage in other areas where vaccine hesitancy and complacency have undermined 
vaccination efforts. 2  
 
Over the last decade, increased recognition of that adolescents are an important reservoir of 
several vaccine preventable diseases has increased attention on vaccination of this age group 
specifically.  For example, the highest proportion of pertussis cases occurs among 11-18 year 
olds, 3 ~75% of new HPV infections occur in 15-24 year olds, 4 and 13-21 year olds have the 
highest incidence of meningococcal disease outside of infancy.  5 These illnesses can affect 
entire communities, making adolescent vaccination against these infections a major public health 
priority. The “adolescent platform” of vaccines was initially developed in 1997 with 
recommendations for adolescent varicella, hepatitis B, tetanus, and measles–mumps–rubella.6 
Over time, the vaccines comprising the adolescent platform have changed to reflect changes in 
the vaccination schedule. Currently, the platform consists of four vaccines routinely 
recommended for all U.S. adolescents:7 the tetanus–diphtheria–acellular pertussis (Tdap), 
meningococcal (MCV), human papillomavirus (HPV), and influenza vaccines. With the 
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exception of annual influenza vaccination, all of these vaccines are preferentially recommended 
for 11–12-year-olds, but can be given throughout adolescence if not provided previously.8 
 
Of these four vaccines, only Tdap and MCV have surpassed or nearly reached the U.S. Healthy 
People 2020 goal coverage level of 80%. As of 2013, Tdap uptake among those aged 13–17 
years was 86.0% and MCV was 77.8%.9 HPV vaccination levels lag significantly, with only 
57.3% of girls and 34.6% of boys aged 13–17 having begun the three-dose series. Series 
completion is significantly lower, at 37.6% and 13.9% for girls and boys, respectively. Of 
concern, among girls there have been minimal increases in HPV vaccination over the last 3 
years.10 Influenza vaccination is also dismally low, with only 42.5% of adolescents receiving this 
vaccine in the 2012–2013 season.11 
 
Since the development of the adolescent platform, there have been hundreds of studies 
describing the variety of barriers to vaccinating this population.12-23 This work has laid the 
foundation for more recent research aimed at developing and evaluating interventions to increase 
adolescent vaccination.24-26 These studies have centered primarily on HPV and influenza 
vaccines, given their lower coverage levels. This review focuses on a selection of recent (from 
2006 to present) intervention studies for improving adolescent vaccination. It includes select 
examples from three levels of possible intervention: parents/patients, practice, and population 
(Figure 1). This review specifically focuses on interventions that, in our opinion, go beyond the 
“usual suspects” in that they are either entirely novel, have had little prior examination, or add a 
twist (usually technology-related) to the standard evidence-based interventions for vaccination 
recommended by the U.S. Task Force on Community Preventive Services (USTFCPS).27, 28 As 
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this is not a systematic or comprehensive review, studies related to school mandates for vaccines 
are not included because policy interventions such as this are outside of the scope of this 
manuscript. Also not included are studies focused on the provision of vaccines in schools, for 
example, through school-located clinics, as this large and diverse subject potentially warrants its 
own review. 
 
Tested Interventions That Hold Promise for Increasing Adolescent Vaccination 
The studies described below represent a selection of interventions that appear to be potentially 
useful for increasing adolescent vaccination. Many of these interventions use technology to 
support their implementation. 
 
Parent/Patient-Level Interventions 
Text messaging to parents. Parent and clinician “reminders” for vaccines coming due, and 
“recall” for vaccines past due, are one of several evidence-based approaches for improving 
vaccination endorsed by the USTFCPS.27 Most studies of this communication strategy have 
focused on paper- or telephone-based reminder systems. However, with the increased use of 
mobile phones for health-related activities,29 several groups have recently begun to examine the 
impact of text message reminder/recall on adolescent immunization. Kharbanda et al.30 examined 
the impact of text message reminders for on-time receipt of first and second doses of HPV 
vaccine among parents of adolescents (aged 9–20 years) from nine pediatric sites in New York 
City. After controlling for variations in insurance and intervention implementation, adolescents 
of the 124 parents enrolled in the text messaging program had approximately two times the odds 
of receiving HPV doses on time when compared with controls. Subsequent studies found similar 
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effects for MCV and Tdap vaccines (AORs among intervention group, 2.17–4.57, depending on 
the assessment time and vaccine).31 Moreover, in a significantly larger study (n=3,790 
intervention, n=3,784 control), effectiveness of text messaging for improving influenza 
vaccination was also demonstrated (relative rate ratio=1.09 for intervention vs control), though 
these analyses included children aged 6 months to 18 years, and did not provide adolescent-
specific results.32 Other groups are engaged in text messaging studies for adolescents or other 
populations,33-38 and it appears that a systematic review on this approach will be forthcoming.39 
Based on these studies, the use of text messaging to improve adolescent vaccination, particularly 
the completion of multi-dose series, seems promising. 
 
Parent/patient-created educational materials. Patient- or parent-based education, when used 
without other intervention strategies, is deemed by USTFCPS as an approach with “insufficient 
evidence” to endorse as a strategy to improve vaccination rates.28 However, these analyses were 
done primarily before newer educational modalities were used—for example, using community 
input to design the educational materials (i.e., creation of “patient-centered” information), or 
web-based tools for information dissemination. 
 
Recently, there has been a push in health communication toward making educational materials 
more “patient-centered.”40-42 Patient-centeredness refers to the notion that input from the 
expected “end users” (in this case adolescent patients/parents) into the development of an 
intervention can significantly improve its acceptability and effectiveness.42 A few studies have 
begun exploring patient-centered approaches to developing educational materials related to 
adolescent vaccination. Gargano and colleagues43 described the development and evaluation of a 
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parent educational brochure about adolescent vaccines that was created in close collaboration 
with focus group and pilot testing feedback from parents of middle and high school students 
where the intervention was to be implemented. Overall, 67% of parents recalled receiving the 
brochure, 90% of whom read it. Moreover, more than half discussed the brochure with family or 
friends. The authors of this study indicate that future work will evaluate the impact of the 
intervention on actual adolescent vaccination levels. 
 
A second study by Katz et al.44 described the development of a comic book that included critical 
input by parents in rural Ohio as part of a multilevel intervention to promote HPV vaccination. 
Using an iterative approach, parents and the research team collaboratively created a storyline, 
text, and artistic elements that were developed into a comic book. When the comic book was 
evaluated among 20 additional parents, it significantly improved their knowledge and positive 
attitudes about HPV vaccination. Moreover, among the 19 adolescents whose parents gave 
permission for them to also read the book, most had positive responses to the materials and 
indicated that the format and information were useful and engaging. Future studies by this group 
will examine the impact of the comic book on adolescent attitudes and utilization of the vaccine 
among a larger sample. 
 
Web-based educational materials for parents. Web-based approaches to health 
communication have been studied in many domains.45-52 A few groups have examined this 
communication modality with regard to adolescent vaccination specifically. Starling and 
colleagues53 developed a website called “GoHealthyGirls” to educate and inform parents and 
their adolescent daughters about HPV vaccines and infection. Beta-testing of this multimedia 
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website among a diverse set of 63 parents and their daughters demonstrated that, after viewing 
the website, parents reported significantly more-positive attitudes about HPV vaccination, and 
higher perceived risk for HPV infection. The authors report that this website will be more 
thoroughly evaluated in an upcoming RCT. 
 
Another approach that has begun to be evaluated with regard to adolescent vaccination is 
whether websites providing parents with “tailored” information about vaccines influence vaccine 
uptake. Message tailoring involves the individualization of educational materials to reflect each 
user’s unique experiences, beliefs, and concerns. Message tailoring has been found to be an 
effective strategy for improving adherence with a variety of preventive health behaviors in many 
diverse populations, but has only recently been applied to vaccination.54-56 Using an RCT design, 
our group (Dempsey et al.57) is examining several interventions that provide tailored material to 
parents about adolescent vaccines via web-based platforms such as iPads or home computers. 
Though final results are not yet available, preliminary results for HPV vaccines specifically 
demonstrate that tailored materials are superior to untailored materials for improving parental 
HPV vaccination intentions. A study by Gerend and colleagues58 found similar results when 
tailored messages about HPV vaccination were provided to young adult women. Though these 
results are encouraging, the impact of tailored messaging on actual HPV vaccine utilization 
remains to be determined. Data in this regard should be available from our group within the next 
year. 
 
Web-based communication about vaccines extends beyond viewing of content-oriented web 
pages. Nan et al.59 examined the role of blogs on HPV vaccination attitudes and behavioral 
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intention. In their study of 341 young adult men and women, they found that exposure to 
“negative” blogs significantly reduced perceptions of vaccine efficacy and safety and vaccination 
intent when compared with a control group of no blog exposure. Surprisingly, exposure to 
“positive” blogs had no effect when compared with controls. This work, combined with that 
focused on vaccination in other populations,60-74 supports the notion that web-based social media 
can play a powerful role in mediating vaccination intentions and decisions. 
 
Population-Level Interventions 
Social marketing. Social marketing is a “process that applies traditional marketing principles 
and techniques to influence target audience behaviors that benefit society as well as the 
individual.”75 Its concepts include components of several health behavior theories, social 
psychology, marketing science, and communication research. The application of social 
marketing to adolescent vaccination was explored by Cates and colleagues76,77 in two studies. In 
the first, social marketing principles were used to design educational materials about HPV 
vaccination targeted to mothers of 11–12-year-olds and distributed across four counties in North 
Carolina.76 The study found modest impacts of the intervention, with HPV vaccination levels 2% 
higher among 9–13-year-olds in two of four intervention counties compared with 96 non-
intervention counties, when assessed 6 months after the intervention period. In addition, a high 
proportion of mothers surveyed from the intervention counties remembered seeing the campaign 
materials, and the majority “took action” as a result, for example, talking with their daughter’s 
provider about the vaccine. 
 
The second study focused on parents of preteen (9–13-year-old) boys and their healthcare 
providers.77 It included several types of parent educational materials as well as a webinar, tip 
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sheet, and website resource list for providers. After controlling for race, age, and Vaccines For 
Children program eligibility, the data showed a 34% higher likelihood of receiving an HPV 
vaccine dose during the 3-month intervention period for boys residing in the 13 intervention 
counties compared with those residing in the 15 control counties. However, the effect did not 
appear to be sustained, as there were no differences between control and intervention groups 
when data were assessed after the intervention period was complete. 
 
Centralized reminder/recall. Many studies have demonstrated the effectiveness of parent 
reminder/recall strategies for improving vaccination.27, 28 Typically, these interventions are 
instituted at the practice level, and use mail- or phone-based approaches. However, with 
advances in computerized records and immunization information systems, a novel innovation of 
reminder/recall is “centralizing” the process such that a coordinating agency (i.e., health 
department), rather than an individual practice, implements the service. Centralized 
reminder/recall for adolescent vaccination at the population level has begun to be examined. 
Szilagyi et al.78 implemented a centralized reminder/recall approach (telephone or postal mail) 
via an MCO in a study that assessed all four vaccines in the current adolescent platform and 
included 4,115 adolescents (aged 11–17 years) seen at one of 37 primary care practices in central 
New York. Both the telephone and postal mail arms of the study had immunization levels that 
were 4–9 percentage points greater than the control group (no reminders) for each assessed 
vaccine. These increases in vaccination are similar to those found in other mail-based 
reminder/recall studies, but required significantly less effort on the part of practices to 
implement. A similar finding was published recently by Chao and colleagues,79 who reported a 
three-dose completion rate nearly 10% higher in a reminder letter group compared with a control 
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group. By contrast, Patel et al.80 found that an automated reminder system did not increase HPV 
vaccine completion rates. It may be that more work needs to be done to determine the most 
effective ways to implement these kinds of reminder/recall systems. 
 
A study by Kempe and colleagues81 compared practice-based versus population-based recall 
directly, though the focus was on children aged 19–35 months. In this study, the intervention 
group consisted of seven counties in Colorado where reminder/recall was implemented by local 
county health departments using the state immunization registry. The control group consisted of 
primary care practices in seven additional counties that were invited to do practice-based 
reminder/recall using the immunization registry, with training available if desired. Overall up-to-
date vaccination status was approximately 6 percentage points higher among children in the 
intervention versus control counties (p<0.001). However, an important finding of the study was 
that only 5% of practices in the intervention arm actually implemented practice-based 
reminder/recall strategies. This latter finding further supports the utility of centralizing the 
vaccination reminder/recall process. 
 
Practice-Level Interventions 
Automated clinical decision support. A recent meta-analysis of automated decision support 
tools such as on-screen “practices alerts” embedded within the electronic medical record (EMR) 
at the point of care demonstrated a 3.8% improvement in vaccination adherence generally.82 
Several groups have examined the role that practice alerts can have on improving adolescent 
vaccination specifically. In an initial study, Mayne et al.83 demonstrated that implementing a 
practice alert for HPV vaccination in the EMR of 11 pediatrics practices in Philadelphia resulted 
in a higher proportion of parents reporting they had discussed the vaccine with their child’s 
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provider, compared with parents from practices that did not have the alert in place (84% vs 70%, 
p=0.02). In a larger RCT of this intervention, the clinician-focused practice alert resulted in HPV 
vaccination initiation levels that were 8 percentage points higher than in offices with no 
intervention in place (24% vs 16%), and 6 percentage points higher than in offices where a 
family-focused educational intervention was provided instead (18%).84 However, for subsequent 
HPV vaccine doses, the family-focused intervention was more effective than the practice alert 
intervention. 
 
In a separate study, Stockwell and colleagues85 used a randomized cluster-crossover design to 
evaluate the impact of EMR-based practice alerts for influenza vaccination among children (aged 
6 months to 17 years) seen at four primary care clinics in New York City. They found a 
measurable increase in influenza vaccination during periods when the reminder was active 
compared with when it was not (76.2% vs 73.8%, p=0.27), with greater effects present in the 
later months of the influenza season. However, the authors did not report on whether there were 
any differences in the intervention’s effect by patient age, precluding conclusions about this 
intervention for adolescent vaccination specifically. 
 
Another recent study by Perkins et al.86 evaluated a multicomponent practice intervention 
involving multiple visits to practices, education on HPV-related health consequences and HPV 
vaccine safety and efficacy, feedback on vaccination rates relative to other practices, and 
maintenance of certification rewards for improving practice-wide HPV vaccination rates. They 
reported sustained increases in HPV vaccination rates of female and male 11–21-year-olds in 
intervention compared with control clinics. 
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Assessment, Feedback, Incentives, and eXchange variations. Assessment, Feedback, 
Incentives, and eXchange (AFIX) describes another evidence-based practice recommended by 
the USTFCPS to improve vaccination levels.27, 28 AFIX generally involves a public health 
worker collaborating with practices to systematically assess vaccination levels, share this 
information with the practice, negotiate incentives for improvement, and exchange best practices 
between clinical sites. Past experience demonstrates that AFIX strategies can boost vaccination 
substantially.8 However, a limitation of the “classic” AFIX approach is its resource 
intensiveness, with in-person interventions being the norm. Three studies, all by the same 
research group, have begun exploring “virtual AFIX” strategies focused on adolescent 
vaccination. In the first, which included 17 federally-qualified health centers in North Carolina 
serving 7,800 adolescent patients, clinic coordinators from each center attended a 1-hour, one-
on-one webinar-based “AFIX visit” by a staff member from the state health department’s 
immunization branch.87 Part of this visit also provided training on how to use the state’s 
immunization registry to generate adolescent vaccination reminder letters for patients not up to 
date. Assessment at the 1-month post intervention period demonstrated a 1%–2% increase in the 
proportion of adolescents up to date with recommended adolescent vaccines when compared 
with pre-intervention. Though the increase was modest, the authors concluded that these gains 
were significant when balanced by the substantial reduction in personnel time afforded by the 
virtual process. A follow-up study included 91 primary care clinics that were randomized to 
receive an in-person AFIX consultation, a virtual AFIX consultation, or no consultation.88 At the 
5-month follow-up assessment, it was found that the in person and virtual AFIX consultations 
were equally effective for improving adolescent vaccination, and both were better than no 
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consultation. The impact of AFIX was greatest for younger adolescents, with vaccination levels 
among 11–12-year-olds 1.5%–4.7% higher in either AFIX arm (depending on the vaccine 
assessed) when compared with the control arm. A process evaluation comparing the in-person 
and virtual AFIX strategies demonstrated that the latter was significantly less expensive ($100 vs 
$152 per clinic).89 
 
Tested Interventions With Mixed Results Deserving Further Investigation 
Significantly fewer articles have been published on “negative studies”—that is, studies where the 
intervention appeared to have had little to no effect on adolescent vaccination rates. Because of 
this, it is difficult to classify them by their level of intervention (patient/parent, practice, 
population). Instead, we have classified these interventions by type into two categories: free 
vaccines/financial incentives and parent education alone. 
 
Providing Free Vaccines/Financial Incentives 
Reducing out-of-pocket costs for vaccination, for example, by providing vaccines for free, is 
another recommended, evidence-based strategy to improve vaccination rates.27, 28 To our 
knowledge, there has been only one U.S.-based study that has examined the use of free vaccines 
on adolescent vaccination.90 Broader studies published on adolescent and young adult HPV 
vaccination suggest a limited effect of providing free vaccines.90,82 However, methodologic 
challenges make interpretation of these studies difficult (e.g., provision of free vaccine may be 
confounded with SES and other factors that may be associated with initiation or completion of 
the three-dose series). 
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With respect to incentivized vaccination, Mantzari and colleagues91, 92 performed an RCT in 
England that examined the impact of providing a $73 shopping voucher ($29 for first dose, $7 
for second dose, $29 for third dose) on HPV vaccine series initiation and completion among girls 
aged 16–18 years. Text message reminders for second and third doses were also provided. The 
intervention led to significant and substantial increases in series completion, with double to 
quadruple the rates found in the control condition (22.4% vs 12% in girls not previously 
contacted and 12.4% vs 3% in previous non-responders). The relatively low overall completion 
rates, however, indicate that other approaches in addition to incentives may be required to 
achieve high vaccination rates. Finally, a systemic review by Wigham et al.93 on the influence of 
financial incentives to parents for increasing preschool vaccination found insufficient evidence to 
conclude this strategy was effective, suggesting more research may be necessary to fully 
understand the effectiveness and cost effectiveness of incentivized HPV vaccination. 
 
Parent/Patient Education or Messaging Alone 
The type of adolescent vaccination interventions with the largest number of studies is 
parent/patient education or messaging alone (i.e., without other intervention components). Most 
of the studies in this domain focus on HPV. Results in this area are quite mixed, with some 
studies showing a positive effect and others showing no effect. However, a recent systematic 
review by Fu and colleagues94 of educational and messaging interventions specifically to 
increase HPV vaccine acceptance included 33 articles, most of which were published prior to the 
vaccine’s licensure in the U.S. The review concluded that there was insufficient evidence for 
recommending any specific parent or patient educational approach for improving HPV 
vaccination intentions, though the authors did note that, in general, such interventions appeared 
to be more effective when targeted to adolescents rather than their parents. Two recent 
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messaging studies deserve mention here. One study found that asking parents a rhetorical 
question (e.g., Do you want to protect your daughter from cervical cancer?) led to greater 
intention to vaccinate, but this increased intention did not translate into higher vaccination rates 
(the intervention was delivered by phone, not in a clinical setting).95 Another recent study found 
that a brief messaging intervention emphasizing male-specific HPV vaccine benefits and 
altruistic motivation led to higher HPV vaccine acceptability among a sample of college men, 
but effects on actual vaccination rates were not examined.96 Brief messaging interventions may 
increase intentions, but likely have a relatively short-lived effect on behavior. Future research 
should examine the effects of such interventions when delivered in a clinical setting where HPV 
vaccine can be delivered shortly after messaging is complete. 
 
Interventions That Have Worked in Other Settings but Have Not Been Tested 
in Adolescents 
Below, we describe two strategies that studies suggest may useful for improving compliance 
with adolescent vaccination, but have not yet been rigorously tested. These interventions may be 
useful targets for future research. 
 
Provider Training on How to More Effectively Talk About Vaccines 
One promising area for future intervention research relates to improving provider 
communication strategies for adolescent vaccination, particularly HPV and influenza, by 
providing training and materials that providers can use when they encounter vaccine-hesitant 
parents. Studies of vaccination conversations between providers and parents of young children 
(aged 1–19 months) demonstrated that parents had a significantly higher odds of resisting 
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vaccine recommendations when providers used a “participatory” approach (i.e., So, what do you 
want to do about shots?) rather than a “presumptive” approach (i.e., We need to do some shots 
today.)97 In keeping with this finding, strong provider recommendation has been shown as a key 
factor in adolescent vaccination in numerous studies.98-107 However, research demonstrates that 
physicians discuss some adolescent vaccines, particularly HPV, differently than others.104, 108-110 
Given this, recent research has begun to focus on provider interventions to train them to talk 
about all adolescent vaccines in a way that is more conducive to vaccine acceptance, and to use 
proven communication strategies such as motivational interviewing111, 112 when vaccine 
hesitancy is encountered. 
 
Providing Vaccines in Pharmacies 
Pharmacies are increasingly become a vaccination site, as they provide convenience and access 
on “off” hours such as weekends and evenings.113 Adults are the greatest users of pharmacy 
vaccination services, but many communities also provide vaccines to adolescents.114 Influenza 
vaccines are the most commonly administered vaccine in pharmacies, but other vaccines are also 
available.115, 116 Several intervention studies demonstrate that pharmacy-based vaccination can be 
effective at improving adult vaccine coverage.117-119 Some groups have recently begun to explore 
the potential for pharmacies to improve adolescent vaccination, particularly for HPV.115, 120 
Multiple barriers have been identified, including reimbursement for vaccination and tracking of 
provided vaccines.115, 121, 122 However, given the proven success of pharmacists as vaccinators of 
adults, finding ways to implement a similar approach for adolescent vaccination may be a fruitful 
area for future study. 
 
Conclusions 
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A variety of approaches toward increasing adolescent vaccination rates have been evaluated, 
with much emphasis, understandably, on HPV vaccination. Several show promise, others appear 
to have minimal effect, and still others show mixed results. Research findings are consistent 
across studies that weak or no recommendations from healthcare providers are primary drivers of 
poor HPV vaccine uptake. As a result, it will be important to continue to develop and evaluate 
interventions that target practices and healthcare providers, including automated EMR-based 
reminder systems and improving provider communication skills. 
 
Educational interventions directed at parents and adolescents may not be hugely effective. 
However, recent research indicates that many parents remain unaware that HPV vaccine is 
routinely recommended for boys as well as girls.123 Without such awareness, these parents would 
not know to ask for their sons to be vaccinated. Message-framing interventions directed at 
parents, adolescents, and young adults show promise, particularly around increasing intentions to 
vaccinate. There is some evidence, however, that the effect of brief messages may be time-
limited. Therefore, it will be important to evaluate the effect of different messaging strategies on 
parent/patient activation and vaccine receipt, when the messages are delivered in a setting where 
vaccines can be delivered.  
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